1. Which of the following irritable bowel syndrome (IBS) subtypes best describes an individual with IBS who has 90% of hard lumpy stools and abdominal pain at least 4 days of the week?

2. Which of the following medications is a sodium/hydrogen exchanger 3 inhibitor?

3. Which one of the following statements accurately describes the safety profile of the secretagogues available for IBS-C treatment?

« Return to Activity